(Q47987707)

7 February 2018

title

Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China (English)

1 reference

7 February 2018

1 reference

1 reference

1 reference

Guixian Zhao

1

1 reference

7 February 2018

Qian Chen

2

1 reference

7 February 2018

Yongheng Huang

3

1 reference

7 February 2018

Zhenxin Li

4

1 reference

7 February 2018

Xinghuai Sun

5

1 reference

7 February 2018

Ping Lu

6

1 reference

7 February 2018

S Yan

7

1 reference

7 February 2018

Min Wang

8

1 reference

7 February 2018

Guohong Tian

9

1 reference

7 February 2018

publication date

3 November 2017

1 reference

7 February 2018

published in

Journal of Neurology

1 reference

7 February 2018

volume

265

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

33-40

1 reference

7 February 2018

Neurological outcome and predictive factors of idiopathic optic neuritis in China

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Clinical characteristics of optic neuritis in Hong Kong population: 10-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chinese Han patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

The putative acceleration of optic neuritis when combined with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8651-4

Clinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in China

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29101456

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29101456

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29101456

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00415-017-8651-4

1 reference

7 February 2018

1 reference

7 February 2018